DiviDrip · EMBC

EMBC — Embecta Corp.

EMBC is Embecta Corp. (Healthcare). Trading at $3.32. Current dividend yield: 13.83%.

Dividend snapshot

Annual dividend rate$0.46
Current yield13.83%
Payment frequencyQuarterly
Next ex-dividend dateMay 28, 2026
Most recent payment dateMar 17, 2026
Last payment amount$0.1500
5-year dividend CAGR
3-year dividend CAGR25.99%
Payout ratio32%
Market cap$197M
ExchangeNMS

Recent dividend payments

DateAmount / share
2026-02-27$0.1500
2025-12-05$0.1500
2025-08-29$0.1500
2025-05-28$0.1500
2025-02-28$0.1500
2024-12-06$0.1500
2024-08-27$0.1500
2024-05-24$0.1500

About EMBC

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Track EMBC in DiviDrip

Add EMBC to your portfolio on DiviDrip to track every buy, DRIP reinvestment, and dividend payment in one place. Free, no credit card, no upsell — built by dividend investors, for dividend investors.

Data refreshed 2026-05-24. Not investment advice. Yields and prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow

Made with Emergent